Bicillin L-A — Class II drug recall D-0373-2024
Terminated recall by Mckesson Medical-Surgical Inc. Corporate Office, reported 2024-03-20, distributed in AZ, NM, UT. cGMP Deviations: Products were stored outside the drug label specifications.
| Recall number | D-0373-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA, United States |
| Recall initiated | 2024-02-07 |
| Classified | 2024-03-08 |
| Reported by FDA | 2024-03-20 |
| Terminated | 2024-08-14 |
| Distributed | AZ, NM, UT |
| Quantity | 70 vials |
| Reason classes | labeling, cgmp |
| NDC | 60793-0701-10 |
Product
Bicillin L-A (Penicillin G Benzathine) 1.2, MMU / 2 mL Injection Prefilled Syringe 2 mL, Rx only, Mfg: Pfizer Pharmaceuticals, NDC 60793-0701-10
Reason for recall
cGMP Deviations: Products were stored outside the drug label specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0373-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.